Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_assertion type Assertion NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_head.
- NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_assertion description "[The frequency of CXCL12 AA genotype was significantly higher in a group of patients with lymph node metastasis (23%) compared with those without metastasis (7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_provenance.
- NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_assertion evidence source_evidence_literature NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_provenance.
- NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_assertion SIO_000772 17785557 NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_provenance.
- NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_assertion wasDerivedFrom befree-2016 NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_provenance.
- NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_assertion wasGeneratedBy ECO_0000203 NP628185.RA2NbDX6-MrxOM904bb57CDBc6S_5OapsV5RmHUI-Tuv4130_provenance.